This study represents the first examination of how pharmaceutical industry representatives involved in marketing view the use of health outcome and pharmacoeconomic information by health care ...

The use of pharmacoeconomic data in hospital formulary decisions was explored. Data were collected from pharmacist members of pharmacy and therapeutics (P&T) committees in 204 Florida hospitals.

Both pharma companies and the MOH began to evaluate new treatments based on pharmacoeconomic modelling. Pharma companies started to include it in their market access departments and then these ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...